GUIDEPOINT INSIGHTS AACR IN-PERSON GROUP MEETINGS

On Sunday, April 16th and Monday, April 17th, Guidepoint Insights will be hosting a series of live group meetings featuring KOLs who will dive deeper into AACR (American Association for Cancer Research) clinical data updates.

 

To request access to AACR group meetings, complete the form below.

 

    Sunday, April 16th

    10:00 AM ET - Neil Vasan

    • Breast Cancer | Oncologic Drugs Advisory Committee-Member at U.S. Food and Drug Administration

    11:00 AM ET - Hatim Husain

    • Novel Therapeutics and Lung Cancer | Associate Professor of Medical Oncology at University of California - San Diego

    12:00 PM ET - Roger Lo

    • RAF Pathway and Melanoma | Professor and Director, Melanoma Clinic In Dermatology at University of California, Los Angeles

    1:00 PM ET - Ryan Corcoran

    • KRAS, RAF and Colorectal Cancer | Director of the Gastrointestinal Cancer Center Program and the Scientific Director of the Termeer Center for Targeted Therapy at Massachusetts General Hospital

    2:00 PM ET - Poulikos Poulikakos

    • KRAS, RAF and Other MAPK Targets | Associate Professor at Icahn School of Medicine at Mount Sinai

    Monday, April 17th

    9:00 AM ET - Khandan Keyomarsi

    • Synthetic Lethality | Professor at The University of Texas M. D. Anderson Cancer Center

    10:00 AM ET - Jason Luke

    • Immunotherapy and Melanoma | Associate Professor at University of Pittsburgh School of Medicine

    11:00 AM ET - Asfar Azmi

    • KRAS and Other MAPK Targets | Leader Molecular Therapeutics Research Program at Karmanos Cancer Institute

    2:00 PM ET - Cesar Perez

    • Phase 1 Trials - PI3K and other Novel Agents | Director of Drug Development at Florida Cancer Specialists & Research Institute, LLC

    3:00 PM ET - Timothy Yap

    • Synthetic Lethality and Gynecologic Cancers | Medical Director at The University of Texas M. D. Anderson Cancer Center

     

    AACR meetings will not be recorded and transcripts will not be available after the event.